Search for: "Hoffmann v. Hoffmann" Results 201 - 220 of 463
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Oct 2008, 5:52 am
On this basis there was no infringement.* The prior art cited by ACS did not emcompass the invention described in Ancon's patent, so the challenge to its validity failed.The IPKat notes the judge's reliance on, among other decisions, that of the House of Lords in Kirin-Amgen Inc. v Hoechst Marion Roussel Ltd, in which Lord Hoffmann rewrote, clarified or invented the British law on claim construction, depending on how you read the law that came before it. [read post]
29 Dec 2023, 11:00 am by Henry P Yang
While the readers may remember that in InterDigital v Lenovo [2023] EWHC 539 (Pat) Mellor J adopted an exclusionary approach with comparables, disregarding most and eventually relied on a single prior licence LG 2017 to derive all the rates in that Judgment, Marcus Smith J differed from that approach and considered that at least in this case, the comparables only have value if an inclusive approach is taken. [read post]
6 Nov 2008, 4:49 pm
Hoffmann-LaRoche, Ltd., 368 U.S. [read post]
12 Jun 2023, 12:53 am by INFORRM
Last week in the courts On 6 to 9 June 2023, the trial in the case of LCG v OVD continued before Collins Rice J. [read post]
18 Nov 2010, 1:59 am by INFORRM
“ On the issue of the “superinjunction” the judgment cited the central cases concerning open justice including Scott v Scott, A-G v Leveller and ex parte Kaim Todner. [read post]
2 Nov 2011, 12:57 pm
by its mRNA (the encoding gene) in T-cell and B-cell lymphomas, and (v) the information that Neutrokine-? [read post]
8 Jul 2010, 9:39 am by David Smith
HHJ Rylands assessed the claim for mesne profits on the basis of the decision in Ministry of Defence v Ashman [1993] 25 HLR 514. [read post]
8 Jul 2010, 9:39 am by David Smith
HHJ Rylands assessed the claim for mesne profits on the basis of the decision in Ministry of Defence v Ashman [1993] 25 HLR 514. [read post]
17 Apr 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Kubin ruling extends KSR logic to biotech (Managing IP) (Technology Transfer Tactics) (Patent Docs) (Patent Docs) Evista (Raloxifene) Xigris (Drotrecogin alfa) - Court finds Ariad patent claims in suit v. [read post]
30 Dec 2009, 2:00 am
(EPLAW) Thrombin JM - Pharma company avoids injunction by dropping competitive keyword ads: King v ZymoGenetics (Technology & Marketing Law Blog) Vytorin (Ezetimibe, Simvastatin) - US: Schering files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) Xeloda (Capecitabine) - US: Hoffmann-La Roche files patent infringement complaint against Roxane following Para IV challenge (Patent Docs)   [read post]
19 Apr 2012, 4:44 am by Ronald Podolny
Mere foreseeability of a consequence does not satisfy the requirement of intention: [43] (Lord Hoffmann). [read post]